Trial
NCT06058156
Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
Kymera Therapeutics, Inc.
Condition
Atopic Dermatitis
Intervention
SAR444656 (KT-474)
Why stopped
Sponsor decision. Not related to safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-11